Advertisement

Advertisement

Quick Chats

hematologic malignancies

By The ASCO Post Staff / Quick Chats

Andrew D. Zelenetz, MD, PhD, and Stephen J. Schuster, MD, on CAR T Cells for Hematologic Malignancies: Where We’re At

multiple myeloma

By The ASCO Post Staff / Quick Chats

Paul G. Richardson, MD, and Peter M. Voorhees, MD, on Multiple Myeloma: Surveying the Evolving Landscape of Up-Front Drugs

colorectal cancer

gastrointestinal cancer

By The ASCO Post Staff / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Liquid Biopsies for Colorectal and Other GI Cancers

colorectal cancer

genomics/genetics

By The ASCO Post Staff / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Colorectal Cancer: Molecular Testing and Interpreting an NGS Report

Advertisement

Advertisement

Jul

14

Today In Oncology

MRD-Guided Therapy With Ibrutinib-Venetoclax or Ibrutinib Alone in Chronic Lymphocytic Leukemia

Metformin in Metastatic Prostate Cancer

Teclistamab for High-Risk, Heavily Pretreated Multiple Myeloma Real-World Data

Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1-KMT2A Alterations

Dual Menin and KAT6A-7 Inhibition Improves Outcomes in NUP98-Rearranged Pediatric AML Models

Advertisement

© 2025 HSP News Service, L.L.C.